This dramatic rise in BACE1 level with cytokine combinations suggested that pro-inflammatory conditions in AD could elevate astrocytic BACE1 and potentially increase amyloidogenic APP processing in astrocytes. The gene discussed is APP; the disease is Alzheimer disease.